Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Caleb Alexander

Showing results (331-340 of 415) with videos related to

Pageof 42
Sort By:
Journal of the American Medical Directors Association|May 22, 2021
State Variation in Chronic Opioid Use in Long-Term Care Nursing Home ResidentsHemalkumar B Mehta, Yong-Fang Kuo, Mukaila A Raji, et al.
Drug Safety|December 23, 2023
Risk of Major Bleeding Associated with Concomitant Direct-Acting Oral Anticoagulant and Clopidogrel Use: A Retrospective Cohort StudyY Joseph Hwang, Hsien-Yen Chang, Thomas Metkus, et al.
Pharmacotherapy|April 1, 2022
Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010-2016Shirin Ardeshirrouhanifard, Huijun An, Ravi K Goyal, et al.
Health Affairs Scholar|October 25, 2024
The opioid industry's use of scientific evidence to advance claims about prescription opioid safety and effectivenessRavi Gupta, Jason Chernesky, Anna Lembke, et al.
Annual Review of Public Health|January 13, 2015
The prescription opioid and heroin crisis: a public health approach to an epidemic of addictionAndrew Kolodny, David T Courtwright, Catherine S Hwang, et al.
Drug and Alcohol Dependence|June 7, 2016
Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: A comparative interrupted time series analysisHsien-Yen Chang, Tatyana Lyapustina, Lainie Rutkow, et al.
Journal of the American College of Cardiology|January 13, 2018
Direct Oral Anticoagulants and Risk of Acute Kidney Injury in Patients With Atrial FibrillationJung-Im Shin, Shengyuan Luo, G Caleb Alexander, et al.
Age and Ageing|June 1, 2023
Single and combined use of fall-risk-increasing drugs and fracture risk: a population-based case-control studyJonathan Hauff, Marietta Rottenkolber, Patrick Oehler, et al.
JAMA Network Open|January 27, 2021
Trends in Oncology Clinical Trials Launched Before and During the COVID-19 PandemicElizabeth B Lamont, Sheila S Diamond, Ron G Katriel, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 14, 2018
Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial FibrillationJung-Im Shin, Alex Secora, G Caleb Alexander, et al.
Pageof 42

Showing results (331-340 of 415) with videos related to

Sort By:
Pageof 42
Journal of the American Medical Directors Association|May 22, 2021
State Variation in Chronic Opioid Use in Long-Term Care Nursing Home ResidentsHemalkumar B Mehta, Yong-Fang Kuo, Mukaila A Raji, et al.
Drug Safety|December 23, 2023
Risk of Major Bleeding Associated with Concomitant Direct-Acting Oral Anticoagulant and Clopidogrel Use: A Retrospective Cohort StudyY Joseph Hwang, Hsien-Yen Chang, Thomas Metkus, et al.
Pharmacotherapy|April 1, 2022
Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010-2016Shirin Ardeshirrouhanifard, Huijun An, Ravi K Goyal, et al.
Health Affairs Scholar|October 25, 2024
The opioid industry's use of scientific evidence to advance claims about prescription opioid safety and effectivenessRavi Gupta, Jason Chernesky, Anna Lembke, et al.
Annual Review of Public Health|January 13, 2015
The prescription opioid and heroin crisis: a public health approach to an epidemic of addictionAndrew Kolodny, David T Courtwright, Catherine S Hwang, et al.
Drug and Alcohol Dependence|June 7, 2016
Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: A comparative interrupted time series analysisHsien-Yen Chang, Tatyana Lyapustina, Lainie Rutkow, et al.
Journal of the American College of Cardiology|January 13, 2018
Direct Oral Anticoagulants and Risk of Acute Kidney Injury in Patients With Atrial FibrillationJung-Im Shin, Shengyuan Luo, G Caleb Alexander, et al.
Age and Ageing|June 1, 2023
Single and combined use of fall-risk-increasing drugs and fracture risk: a population-based case-control studyJonathan Hauff, Marietta Rottenkolber, Patrick Oehler, et al.
JAMA Network Open|January 27, 2021
Trends in Oncology Clinical Trials Launched Before and During the COVID-19 PandemicElizabeth B Lamont, Sheila S Diamond, Ron G Katriel, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 14, 2018
Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial FibrillationJung-Im Shin, Alex Secora, G Caleb Alexander, et al.
Pageof 42